FGFR1 gene amplification in squamous cell carcinomas of the lung: a potential favorable prognostic marker for women and for patients with advanced cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
FGFR1 gene amplification in squamous cell carcinomas of the lung: a potential favorable prognostic marker for women and for patients with advanced cancer
Authors
Keywords
FGFR1, Squamous cell carcinoma of the lung, Non-small cell lung cancer, Prognosis, Women, Advanced cancer
Journal
VIRCHOWS ARCHIV
Volume 472, Issue 5, Pages 759-769
Publisher
Springer Nature
Online
2017-12-22
DOI
10.1007/s00428-017-2282-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cisplatin Increases Sensitivity to FGFR Inhibition in Patient-Derived Xenograft Models of Lung Squamous Cell Carcinoma
- (2017) Clare E. Weeden et al. MOLECULAR CANCER THERAPEUTICS
- Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification
- (2017) Kentaro Inamura Frontiers in Oncology
- Comprehensive Characterization of Molecular Differences in Cancer between Male and Female Patients
- (2016) Yuan Yuan et al. CANCER CELL
- Fibroblast Growth Factor Receptor 1 Gene Amplification in Nonsmall Cell Lung Cancer
- (2016) Rui-Juan Liu et al. CHINESE MEDICAL JOURNAL
- Fibroblast Growth Factor Receptor 1 Overexpression Is Associated with Poor Survival in Patients with Resected Muscle Invasive Urothelial Carcinoma
- (2016) Seungtaek Lim et al. YONSEI MEDICAL JOURNAL
- The clinical pathological characteristics and prognosis of FGFR1 gene amplification in non-small-cell lung cancer: a meta-analysis
- (2016) FaJun Xie et al. OncoTargets and Therapy
- Gender differences in clinicopathological features and prognosis of squamous cell carcinoma of the esophagus
- (2016) Takeshi Nishino et al. Esophagus
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- FGFR as potential target in the treatment of squamous non small cell lung cancer
- (2015) Marcello Tiseo et al. CANCER TREATMENT REVIEWS
- Proposal of a prognostically relevant grading scheme for pulmonary squamous cell carcinoma
- (2015) Wilko Weichert et al. EUROPEAN RESPIRATORY JOURNAL
- Risk Stratification Model for Resected Squamous-Cell Lung Cancer Patients According to Clinical and Pathological Factors
- (2015) Sara Pilotto et al. Journal of Thoracic Oncology
- Fibroblast Growth Factor Receptor Family Members as Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review
- (2015) Norbertus A. Ipenburg et al. Targeted Oncology
- FGFR1 is an adverse outcome indicator for luminal A breast cancers
- (2015) Yu-Jie Shi et al. Oncotarget
- FGFR1 Amplification Is Often Homogeneous and Strongly Linked to the Squamous Cell Carcinoma Subtype in Esophageal Carcinoma
- (2015) Katharina von Loga et al. PLoS One
- FGFR1 mRNA and Protein Expression, not Gene Copy Number, Predict FGFR TKI Sensitivity across All Lung Cancer Histologies
- (2014) M. W. Wynes et al. CLINICAL CANCER RESEARCH
- Clinical significance of fibroblast growth factor receptor-3 mutations in bladder cancer: a systematic review and meta-analysis
- (2014) X. Liu et al. GENETICS AND MOLECULAR RESEARCH
- Prognostic Factors Based on Clinicopathological Data Among the Patients with Resected Peripheral Squamous Cell Carcinomas of the Lung
- (2014) Tomonari Kinoshita et al. Journal of Thoracic Oncology
- Comprehensive Pathological Analyses in Lung Squamous Cell Carcinoma: Single Cell Invasion, Nuclear Diameter, and Tumor Budding Are Independent Prognostic Factors for Worse Outcomes
- (2014) Kyuichi Kadota et al. Journal of Thoracic Oncology
- The 2015 WHO classification of lung tumors
- (2014) W.D. Travis PATHOLOGE
- Inhibitor-Sensitive FGFR2 and FGFR3 Mutations in Lung Squamous Cell Carcinoma
- (2013) R. G. Liao et al. CANCER RESEARCH
- Integrative and Comparative Genomic Analysis of Lung Squamous Cell Carcinomas in East Asian Patients
- (2013) Youngwook Kim et al. JOURNAL OF CLINICAL ONCOLOGY
- T1/T2 non–small-cell lung cancer treated by lobectomy: Does tumor anatomic location matter?
- (2012) Bryan A. Whitson et al. JOURNAL OF SURGICAL RESEARCH
- FGFR1 Amplification in Squamous Cell Carcinoma of The Lung
- (2012) Rebecca S. Heist et al. Journal of Thoracic Oncology
- Genetic Changes in Squamous Cell Lung Cancer: A Review
- (2012) Rebecca S. Heist et al. Journal of Thoracic Oncology
- Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer
- (2012) Hans-Ulrich Schildhaus et al. MODERN PATHOLOGY
- p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma
- (2011) Justin A Bishop et al. MODERN PATHOLOGY
- Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer
- (2010) J. Weiss et al. Science Translational Medicine
- The cancer genome
- (2009) Michael R. Stratton et al. NATURE
- De-regulated FGF receptors as therapeutic targets in cancer
- (2009) Victoria Knights et al. PHARMACOLOGY & THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started